Block T, Shore-Lorenti C, Zebaze R, Kerr P, Kalff A, Perkins A
JBMR Plus. 2023; 7(9):e10791.
PMID: 37701147
PMC: 10494497.
DOI: 10.1002/jbm4.10791.
Newton A, Pask A
Commun Biol. 2020; 3(1):771.
PMID: 33319865
PMC: 7738678.
DOI: 10.1038/s42003-020-01501-3.
Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh Y
Ther Clin Risk Manag. 2018; 14:2029-2049.
PMID: 30464484
PMC: 6225907.
DOI: 10.2147/TCRM.S138000.
Saito A, Ooki A, Nakamura T, Onodera S, Hayashi K, Hasegawa D
Stem Cell Res Ther. 2018; 9(1):12.
PMID: 29357927
PMC: 5778688.
DOI: 10.1186/s13287-017-0754-4.
Lin Y, Chen C, Chou L, Chen C, Kang L, Wang C
Int J Mol Sci. 2017; 18(11).
PMID: 29140298
PMC: 5713390.
DOI: 10.3390/ijms18112422.
Expansion of polyalanine tracts in the QA domain may play a critical role in the clavicular development of cleidocranial dysplasia.
Wu L, Xu X, Liu Y, Ge X, Wang X
J Genet. 2015; 94(3):551-3.
PMID: 26440098
DOI: 10.1007/s12041-015-0551-8.
Regulation of bone formation by baicalein via the mTORC1 pathway.
Li S, Tang J, Chen J, Zhang P, Wang T, Chen T
Drug Des Devel Ther. 2015; 9:5169-83.
PMID: 26392752
PMC: 4572734.
DOI: 10.2147/DDDT.S81578.
A Glutamine Repeat Variant of the RUNX2 Gene Causes Cleidocranial Dysplasia.
Mastushita M, Kitoh H, Subasioglu A, Kurt Colak F, Dundar M, Mishima K
Mol Syndromol. 2015; 6(1):50-3.
PMID: 25852448
PMC: 4369121.
DOI: 10.1159/000370337.
Osteoclastogenic potential of peripheral blood mononuclear cells in cleidocranial dysplasia.
Faienza M, Ventura A, Piacente L, Ciccarelli M, Gigante M, Gesualdo L
Int J Med Sci. 2014; 11(4):356-64.
PMID: 24578613
PMC: 3936030.
DOI: 10.7150/ijms.7793.
Polyalanine repeat polymorphism in RUNX2 is associated with site-specific fracture in post-menopausal females.
Morrison N, Stephens A, Osato M, Pasco J, Fozzard N, Stein G
PLoS One. 2013; 8(9):e72740.
PMID: 24086263
PMC: 3781152.
DOI: 10.1371/journal.pone.0072740.
Glutamine repeat variants in human RUNX2 associated with decreased femoral neck BMD, broadband ultrasound attenuation and target gene transactivation.
Morrison N, Stephens A, Osato M, Polly P, Tan T, Yamashita N
PLoS One. 2012; 7(8):e42617.
PMID: 22912713
PMC: 3418257.
DOI: 10.1371/journal.pone.0042617.
Ectopic expression of SOX9 in osteoblasts alters bone mechanical properties.
Liang B, Cotter M, Chen D, Hernandez C, Zhou G
Calcif Tissue Int. 2011; 90(2):76-89.
PMID: 22143895
PMC: 3272153.
DOI: 10.1007/s00223-011-9550-9.
Runx2 promotes both osteoblastogenesis and novel osteoclastogenic signals in ST2 mesenchymal progenitor cells.
Baniwal S, Shah P, Shi Y, Haduong J, DeClerck Y, Gabet Y
Osteoporos Int. 2011; 23(4):1399-413.
PMID: 21881969
PMC: 5771409.
DOI: 10.1007/s00198-011-1728-5.
Common polymorphisms rather than rare genetic variants of the Runx2 gene are associated with femoral neck BMD in Spanish women.
Pineda B, Hermenegildo C, Laporta P, Tarin J, Cano A, Garcia-Perez M
J Bone Miner Metab. 2010; 28(6):696-705.
PMID: 20407796
DOI: 10.1007/s00774-010-0183-2.
Genetics of osteoporosis: accelerating pace in gene identification and validation.
Li W, Hou S, Yu B, Li M, Ferec C, Chen J
Hum Genet. 2010; 127(3):249-85.
PMID: 20101412
DOI: 10.1007/s00439-009-0773-z.
Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures.
McNamara L
J R Soc Interface. 2009; 7(44):353-72.
PMID: 19846441
PMC: 2842799.
DOI: 10.1098/rsif.2009.0282.
RUNX2 mutations in Chinese patients with cleidocranial dysplasia.
Li Y, Pan W, Xu W, He N, Chen X, Liu H
Mutagenesis. 2009; 24(5):425-31.
PMID: 19515746
PMC: 2734498.
DOI: 10.1093/mutage/gep025.
Repression of Runx2 by androgen receptor (AR) in osteoblasts and prostate cancer cells: AR binds Runx2 and abrogates its recruitment to DNA.
Baniwal S, Khalid O, Sir D, Buchanan G, Coetzee G, Frenkel B
Mol Endocrinol. 2009; 23(8):1203-14.
PMID: 19389811
PMC: 2718746.
DOI: 10.1210/me.2008-0470.
Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.
Xiong Q, Jiao Y, Hasty K, Canale S, Stuart J, Beamer W
Genomics. 2009; 93(5):401-14.
PMID: 19150398
PMC: 2901167.
DOI: 10.1016/j.ygeno.2008.12.008.
Prediction of osteoporosis candidate genes by computational disease-gene identification strategy.
Huang Q, Li G, Cheung W, Song Y, Kung A
J Hum Genet. 2008; 53(7):644-655.
PMID: 18463784
DOI: 10.1007/s10038-008-0295-x.